Nuclear expression of N-myc downstream regulated gene 1/ Ca2+-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer

Experimental and Therapeutic Medicine

Volumn 2, Issue 3, 2011, Pages 471-479

  Kawahara, Akihiko ^a,b   Akiba, Jun ^c   Hattori, Satoshi ^b   Yamaguchi, Tomohiko ^a   Abe, Hideyuki ^a   Taira, Tomoki ^a   Ureshino, Hiroki ^c   Murakami, Yuichi ^c   Watari, Kosuke ^c   Koufuji, Kikuo ^c   Shirouzu, Kazuo ^c   Kuwano, Michihiko ^d   Ono, Mayumi ^c   Kages, Masayoshi ^a,b  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric cancer; N myc downstream regulated gene 1 Ca2+ associated protein 43; Poor prognosis; Tumor angiogenesis; Tumor associated macrophages

Indexed keywords

BIOLOGICAL MARKER; CALCIUM ASSOCIATED PROTEIN 43; CD34 ANTIGEN; CD68 ANTIGEN; N MYC DOWNSTREAM REGULATED PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MUCOSA CELL; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSIS; STOMACH CANCER; TUMOR VASCULARIZATION;

EID: 79953275784     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.222     Document Type: Article

References (42)

1. Van Belzen N, Dinjens WN, Diesveld MP, et al: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77: 85-92, 1997.
2. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA and Lee SW: Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58: 4439-4444, 1998.
3. 2+ compounds. Cancer Res 58: 2182-2189, 1998.
4. Okuda T and Kondoh H: Identification of new genes Ndr2 and Ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res commun 266: 208-215, 1999.
5. Shimono A, Okuda T and Kondoh H: N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83: 39-52, 1999.
6. Qu X, Zhai Y, Wei H, et al: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229: 35-44, 2002.
7. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and Pardee AB: Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60: 749-755, 2000.
8. Bandyopadhyay S, Pai SK, Gross SC, et al: The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63: 1731-1736, 2003.
9. Angst E, Sibold S, Tiffon C, et al: Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95: 307-313, 2006.
10. Fotovati A, Fujii T, Yamaguchi M, et al: 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin Cancer Res 12: 3010-3018, 2006.
11. Maruyama Y, Ono M, Kawahara A, et al: Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66: 6233-6242, 2006.
12. Ando T, Ishiguro H, Kimura M, et al: Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 19: 454-458, 2006.
13. Fukahori S, Yano H, Tsuneoka M, et al: Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J Pediatr Surg 42: 1831-1840, 2007.
14. Koshiji M, Kumamoto K, Morimura K, et al: Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol 13: 2803-2810, 2007.
15. Song YS, Oda Y, Hori M, et al: N-myc downstream regulated gene1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Human Pathol 41: 214-222, 2010.
16. Shah MA, Kemeny N, Hummer A, et al: Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res 11: 3296-3302, 2005.
17. Chua MS, Sun H, Cheung ST, et al: Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20: 76-83, 2007.
18. Nishio S, Ushijima K, Tsuda N, et al: Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 264: 36-43, 2008.
19. Sohda M, Mochida Y, Kato H, et al: Overexpression of Cap43 is associated with malignant status of esophageal cancer. Anticancer Res 29: 965-970, 2009.
20. Kovacevic Z, Fu D and Richardson DR: The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. Biochim Biophys Acta 1783: 1981-1992, 2008.
21. Hosoi F, Izumi H, Kawahara A, et al: N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of IKKbeta expression. Cancer Res 69: 4983-4991, 2009.
22. Murakami Y, Hosoi F, Izumi H, et al: Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochem Biophysical Res Commun 396: 376-381, 2010.
23. Mantovani A, Allavena P and Sica A: Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40: 1660-1667, 2004.
24. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004.
25. Ono M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99: 1501-1506, 2008.
26. Lin EY and Pollard JW: Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67: 5064-5066, 2007.
27. Sica A and Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin invest 117: 1155-1166, 2007.
28. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006.
29. Nakao S, Kuwano T, Tsutsumi-Miyahara C, et al: Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 betainduced neovascularization and tumor growth. J Clin Invest 115: 2979-2991, 2005.
30. Kimura YN, Watari K, Fotovati A, et al: Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci 98: 2009-2018, 2007.
31. Hiraoka K, Zenmyo M, Watari K, et al: Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci 99: 1595-1602, 2008.
32. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
33. Kawahara A, Hattori S, Akiba J, et al: Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep 24: 405-415, 2010.
34. Rothman KJ and Greenland S: Modern Epidemiology. 3rd edition. Lippincott Williams & Wilkins, Philadelphia, 1998.
35. Wakisaka Y, Furuta A, Masuda K, Morikawa W, Kuwano M and Iwaki T: Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development. J Histochem Cytochem 51: 1515-1525, 2003.
36. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P and Bosman FT: Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118: 399-408, 2002.
37. Sibold S, Roh V, Keogh A, et al: Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 581: 989-994, 2007.
38. Maehara Y, Kabashima A, Koga T, et al: Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 128: 408-416, 2000.
39. Inagaki Y, Tang W, Xu HL, et al: Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue. Dig Liver Dis 41: 96-103, 2009.
40. Kovacevic Z and Richardson DR: The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27: 2355-2366, 2006.
41. Rutherford MN, Bayly GR, Matthews BP, et al: The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 15: 362-370, 2001.
42. Stein S, Thomas EK, Herzog B, et al: NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279: 48930-48940, 2004.